A further dissection of TG mobilization from LDs to chylomicrons, including the potential role of MGL in this pathway, may contribute to the search for effective therapeutic target molecules against obesity-associated diseases. This evidence concerns the gene MGLL and obesity due to melanocortin 4 receptor deficiency.